Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €24.25 EUR
Change Today -0.25 / -1.02%
Volume 200.0
As of 6:06 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

pulsion medical systems-reg (PUS) Snapshot

Open
€24.30
Previous Close
€24.50
Day High
€24.30
Day Low
€24.25
52 Week High
04/9/15 - €25.00
52 Week Low
06/27/14 - €18.29
Market Cap
200.1M
Average Volume 10 Days
389.0
EPS TTM
€0.77
Shares Outstanding
8.3M
EX-Date
06/29/15
P/E TM
31.5x
Dividend
€0.86
Dividend Yield
0.16%
Current Stock Chart for PULSION MEDICAL SYSTEMS-REG (PUS)

Related News

No related news articles were found.

pulsion medical systems-reg (PUS) Related Businessweek News

No Related Businessweek News Found

pulsion medical systems-reg (PUS) Details

PULSION Medical Systems SE, together with its subsidiaries, develops, manufactures, and sells systems to monitor, diagnose, and manage the physical parameters of seriously ill and intensive care patients worldwide. The company also produces and markets intravenous diagnostics and sterile disposable items used to monitor patients. It operates in two business units, Critical Care and Perfusion. The company offers PiCCO2 platform, which is used in intensive medical care for treating critically ill patients; PulsioFlex platform that provides technology for use in perioperative medicine; and PiCCO catheter that enables doctors and medical practitioners to monitor the cardiovascular systems of intensive care patients, and to manage the selected therapy. It also provides ProAQT technology, which is used on high-risk patients and during high-risk procedures primarily in the operating room; CeVOX technology that monitors oxygen balance; and LiMON technology to evaluate and monitor liver function. In addition, the company offers ICG PULSION, which is injected into the circulatory system to allow superficial vessels to be visualized; and Photodynamic Eye, a camera unit that is used in various surgical areas. PULSION Medical Systems SE was founded in 1990 and is headquartered in Feldkirchen, Germany. As of February 19, 2014, PULSION Medical Systems SE operates as a subsidiary of MAQUET GmbH.

130 Employees
Last Reported Date: 08/13/14
Founded in 1990

pulsion medical systems-reg (PUS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pulsion medical systems-reg (PUS) Key Developments

PULSION Medical Systems SE to Report Fiscal Year 2014 Results on May 19, 2015

PULSION Medical Systems SE announced that they will report fiscal year 2014 results on May 19, 2015

Maquet And PULSION Announce Distribution Agreement For The PiCCO(R) And ProAQT(R) Hemodynamic Product Lines

Maquet Medical Systems announced a collaboration with PULSION Medical Systems wherein Maquet will distribute PULSION's PiCCO hemodynamic monitoring technology and ProAQT perioperative hemodynamic management products. Nearly 1,000 publications worldwide have confirmed the accuracy and clinical benefit of the PiCCO technology. The PiCCO Technology provides all the necessary information in an easy to interpret graphical visualization, providing clinicians with tools to assist them make therapeutic decisions, based on clear and hard facts. ProAQT visualizes the arterial blood pressure curve providing clinicians with a decision support tool to determine the patient's cardiovascular status and to support decisions regarding clinical interventions. PiCCO Cardiac Output System monitors hemodynamic function in intensive care situations where using standard monitoring parameters such as ECG, non-invasive blood pressure and pulse oximetry do not provide enough information to enable adequate treatment. The PiCCO Technology provides all the necessary information in an easy to interpret graphical visualization that enables faster therapeutic decisions, based on an array of hemodynamic measurements. ProAQT sensor supports goal directed therapy and allows the review of interventions to assess their success. The ProAQT monitoring range has been expanded to include variables such as blood flow, volume responsiveness, afterload and contractility. ProAQT Sensor is a special single-use cardiac output sensor, designed for continuous hemodynamic monitoring with suitable PULSION monitors. The arterial blood pressure curve is utilized to determine the patient's cardiovascular status and to support decisions regarding clinical interventions.

PULSION Medical Systems SE, Special/Extraordinary Shareholders Meeting, Aug 14, 2014

PULSION Medical Systems SE, Special/Extraordinary Shareholders Meeting, Aug 14, 2014. Agenda: To consider the domination and profit and loss transfer agreement.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PUS:GR €24.25 EUR -0.25

PUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Deltex Medical Group PLC 6.63 GBp 0.00
Edwards Lifesciences Corp $130.88 USD -0.94
Hospira Inc $88.27 USD -0.04
ICU Medical Inc $96.91 USD -0.36
LiDCO Group PLC 12.00 GBp 0.00
View Industry Companies
 

Industry Analysis

PUS

Industry Average

Valuation PUS Industry Range
Price/Earnings 23.6x
Price/Sales 4.1x
Price/Book 7.3x
Price/Cash Flow 23.7x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PULSION MEDICAL SYSTEMS-REG, please visit www.pulsion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.